Canada markets closed

Acticor Biotech SAS (7V7.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
3.40000.0000 (0.00%)
At close: 08:59AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 6.02M
Enterprise Value 5.12M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)144.93
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.32

Trading Information

Stock Price History

Beta (5Y Monthly) -0.38
52-Week Change 3-34.36%
S&P500 52-Week Change 322.38%
52 Week High 35.7200
52 Week Low 32.6200
50-Day Moving Average 33.2058
200-Day Moving Average 33.6855

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 515.69M
Implied Shares Outstanding 615.85M
Float 84.09M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-81.35%
Return on Equity (ttm)-797.48%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.68M
Net Income Avi to Common (ttm)-18.65M
Diluted EPS (ttm)-1.6700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.96M
Total Cash Per Share (mrq)0.68
Total Debt (mrq)7.95M
Total Debt/Equity (mrq)2,160.05%
Current Ratio (mrq)1.51
Book Value Per Share (mrq)0.03

Cash Flow Statement

Operating Cash Flow (ttm)-13.76M
Levered Free Cash Flow (ttm)-7.84M